Trice Medical commenced U.S. launch of the Tenex 2nd Generation System, building on the Tenex Health TX platform that has been used in more than 240,000 procedures.
The Tenex 2nd Generation System is designed to expand minimally invasive ultrasonic procedures for the treatment of chronic tendon disease and other musculoskeletal conditions, including calcific deposits, bone spurs, and diabetic foot ulcers.
Trice Medical acquired Tenex Health, a provider of minimally invasive ultrasonic technology for the treatment of chronic pain in soft tissue and bone, in 2021.
Tenex 2nd Generation introduces two longer versions of the ultrasonic handpiece (MicroTips), enabling physicians to reach deeper anatomical structures and improve access to areas such as the shoulder and hip. The system also provides advanced power settings and expanded aspiration and irrigation controls through a redesigned console.
Developed in 2012, the first generation Tenex Health TX System established a minimally invasive ultrasonic approach to treating chronic tendon disease, enabling physicians to intervene early after conservative treatment fails and effectively address the underlying pain.
“We are proud to announce the successful completion of the limited-use release of our Tenex 2nd Generation System and are excited to make this enhanced platform available to a broader market,” said Mike Steen, CEO of Trice Medical. “This milestone represents an exciting new chapter for Tenex technology.”
Trice Medical commenced U.S. launch of the Tenex 2nd Generation System, building on the Tenex Health TX platform that has been used in more than 240,000 procedures.
The Tenex 2nd Generation System is designed to expand minimally invasive ultrasonic procedures for the treatment of chronic tendon disease and other musculoskeletal conditions,...
Trice Medical commenced U.S. launch of the Tenex 2nd Generation System, building on the Tenex Health TX platform that has been used in more than 240,000 procedures.
The Tenex 2nd Generation System is designed to expand minimally invasive ultrasonic procedures for the treatment of chronic tendon disease and other musculoskeletal conditions, including calcific deposits, bone spurs, and diabetic foot ulcers.
Trice Medical acquired Tenex Health, a provider of minimally invasive ultrasonic technology for the treatment of chronic pain in soft tissue and bone, in 2021.
Tenex 2nd Generation introduces two longer versions of the ultrasonic handpiece (MicroTips), enabling physicians to reach deeper anatomical structures and improve access to areas such as the shoulder and hip. The system also provides advanced power settings and expanded aspiration and irrigation controls through a redesigned console.
Developed in 2012, the first generation Tenex Health TX System established a minimally invasive ultrasonic approach to treating chronic tendon disease, enabling physicians to intervene early after conservative treatment fails and effectively address the underlying pain.
“We are proud to announce the successful completion of the limited-use release of our Tenex 2nd Generation System and are excited to make this enhanced platform available to a broader market,” said Mike Steen, CEO of Trice Medical. “This milestone represents an exciting new chapter for Tenex technology.”
Copy to clipboard 
